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Summary  
This report is a bibliometric analysis of the growth rates of publications in the fields 
of stem cells and tissue engineering and regenerative medicine in Iran and compares 
these rates with the rates in other regions of the world. PubMed database was used for 
extraction of relevant publications using MeSH terms. The data were extracted from 
2001-2011 and the address fields of the publications were checked manually in order 
to allocate the publications to a relevant geographical region. Linear regression was 
used for fitting a linear model to the publications of a particular region and the slope 
of the model was used as an indicator of publication growth rate. Statistical 
comparison of the slopes of different regions showed that Iran enjoys a moderate 
growth rate in regards to tissue engineering and regenerative medicine publications 
(including stem cells-related papers) and a low growth rate in regards to general stem 
cells papers. Iran is a regionally dominant country in the field of tissue engineering 
but, not in the field of stem cells. Analysis of the annual growth rate showed a steady 
pattern of growth of tissue engineering papers and a random pattern of growth for 
general stem cells papers. This is an indication of instability in the general stem cell 
research and stability in the field of tissue engineering. Due to equal research funding 
opportunities, this observation is explained by the natural selection of the latter field 
by Iranian biomedical scientists. This natural selection should be supported and 
followed by policy makers in order to take advantage of current research interests and 
capabilities. It is recommended to view and manage stem cells research as a part of 
regenerative medicine not vice versa. 
 
 
2 
 
Background  
The fundamental concepts of enhancement of natural regeneration process in human 
tissues and application of integrated engineering and biological technologies to 
produce tissue substitutes have been the focus of many in-depth experimental and 
clinical studies for more than two decades. The principal elements that have been used 
for materializing these concepts are cells, biomaterials and soluble factors. The 
advances in cell biology and engineering have made the majority of scientists to 
believe that stem cells are the most viable cell sources to be included in the above 
triad. Therefore, tissue engineering and regenerative medicine have been strongly 
linked to the stem cell biology and vice versa. As the result, the science policy makers 
regulate stem cells and tissue engineering research, practice and funding under the 
same policy or two very closely interacting policies.  
Policy making would not be accurate without having a proper account of current, past 
and estimated future research and professional activities. As, still tissue engineering 
and stem cells are predominantly in the research phase and their integration into many 
promised clinical management protocols is pending, measurement of the status of 
these fields is better achieved by assessment of the “research” activities. Bibliometric 
analysis has been long used as one of the useful method for evaluation of activities 
and output of a particular research field, and has been used for preparation of this 
report.  
Several online databases are available for extraction of biomedical bibliometric data 
including, but not limited to, PubMed, Web of Knowledge, Scopus and Google 
Scholar. None of these databases include all the published works and each of them has 
its own search engine and capabilities. The data from each of these databases could be 
3 
 
extracted using the database-specified keywords or the operator-specified keywords. 
Database-specified keywords usually give more consistent results, which will yield 
more accurate conclusions in comparative bibliometric studies. Database-specified 
keywords exist for stem cells, tissue engineering and regenerative medicine in 
PubMed under its MeSH terms, which makes it a very useful source for extraction of 
data in these fields. However, other sources do not include accurately organized 
database-specified keywords for these fields, which necessitate the use of operator-
specified keywords.  
The usefulness of operator-specified keywords in accurate identification of published 
works depends on the field of study. For the “stem cells” literature, there is a high 
possibility that the terms “stem cell” or “stem cells” are mentioned in the title, abstract 
or keywords of a publication. Therefore, “stem cells” or “stem cell” could be used as 
keywords for extraction of stem cells-related publications with high precision from 
most databases. However, the field of tissue engineering and regenerative medicine is 
so heterogeneous that operator-generated keywords will not be able to accurately 
identify the relevant publications, which will highly affect the accuracy of subsequent 
comparative analyses. As the result, this report used PubMed database and its MeSH 
terms for extraction of publications data.  
This report studies the growth rate of publications in the fields of stem cells and tissue 
engineering and regenerative medicine in Iran and compares it with the growth rate in 
other regions of the world.  
Materials and methods  
PubMed has been used for extraction of published articles in the fields of tissue 
engineering and regenerative medicine and stem cells. The search has been conducted 
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using MeSH terms (table 1). The search strategy for retrieval of tissue engineering 
and regenerative medicine publications included:  
“Tissue engineering”[MESH] OR “Regenerative Medicine”[MESH] OR 
Regeneration[MESH] OR "Guided Tissue Regeneration"[Mesh] OR “Cell 
engineering”[MESH] OR “Tissue Scaffolds”[MESH] OR “Biocompatible 
Materials”[MESH] OR “Cell Transplantation”[MESH] OR “Bioartificial 
Organs”[MESH] 
For retrieval of stem cells publications, the following search strategy has been used:  
“Stem cells”[MESH] 
The data were retrieved on 15th January 2013 and the address fields of the retrieved 
publications were checked manually in order to allocate each publication to the 
following geographic locations according to the World Bank’s classification of 
countries:  
Europe, North America, South America, Africa, Australia, East Asia, South 
Asia, Middle East, Iran 
The publications with no address were excluded from the study. As, at the time of 
information retrieval, the indexing of 2012 publications by PubMed was not complete, 
the 2012 publications were not included in this study. The data were retrieved from 
1965 (the date of introduction of the first regenerative medicine-related MeSH term) 
up to 2011. Central Asian countries had only a hand count of publications in these 
fields and so, were excluded from this study. The distribution pattern of the extracted 
publications identified the 14 Iranian publications before the year 2001 as outliers, 
and so, the publications before the year 2001 were excluded from the study.  
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GraphPad Prism 5.01 (August 7, 2007, GraphPad Software, Inc, www.graphpad.com) 
has been used for analysis of data. The general rate of the growth of publications 
output in the above geographical regions was calculated by linear regression analysis 
and calculation of the slope of the best fit line. The resulting slopes in geographic 
regions were compared using Prism’s ANCOVA-based comparison and a p value of 
less than 0.05 was considered statistically significant.  
In addition to the above general growth rate, an annual growth rate (AGR) was 
calculated for each region and field using the following formula:  
Pr(%) 100
Pr
Current Year Total eviousYear TotalAnnual Growth Rate
eviousYear Total
−
= ×  
Results  
A total of 166’216 publications were included in this study of which 118’733 were 
tissue engineering and regenerative medicine papers, and 62’500 were stem cells 
papers of which 15’017 were on the subject of tissue engineering and regenerative 
medicine. Tables 2-4 show the temporal and regional distribution of these 
publications.  
Linear regression was used for determining the best fit linear model to describe the 
general growth rate in each region. As the slope of the model in each region is a true 
representative of the growth rate, the slopes were compared by an ANCOVA-based 
method and showed the highest growth rate in East Asia, Europe and North America, 
moderate growth rate in South America, South Asia, Australia, and Middle East and 
the lowest growth rate in Africa. The growth rate of Iran lied within the group with 
the moderate rate of growth (table 5). The rates of growth of scientifically dominant 
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countries in each region were not significantly different from the regional rates (data 
not shown). Therefore, Iran could be considered as one of the Middle Eastern 
dominant countries in the field of tissue engineering and regenerative medicine. 
Figure 1 shows the growth models of these regions in comparison with Iran. 
Acceleration of the growth rate in Africa after 2007 makes its rate statistically 
insignificant in comparison with the rate of growth of Iran from 2007-2011.  
The percentages of annual growth rates (AGRs) of tissue engineering and regenerative 
medicine are shown in figure 2. The highest growth rate in Iran is observed in 2004 
and steadily decreases afterward. However, it is consistently higher than the average 
AGR in Middle East, Europe, North America and Australia.  
For the stem cells publications, the regions could be classified into four groups 
according to their growth rates (table 6). North America, East Asia and Europe show 
the highest growth rate and their rate in this field is higher than their growth rate in 
regenerative medicine. Iran is classified as a country with low growth rate and its rate 
of growth is significantly lower than the general rate in the Middle East. Therefore, 
Iran is not considered as a dominant Middle Eastern country in the field of stem cells 
research. An interesting finding is that in technologically advanced North American, 
East Asian and European countries the growth rate in stem cells research output is far 
higher than tissue engineering. This difference is not observed in other regions (tables 
5 and 6). The regression models of the growth trends in stem cells publications are 
presented in figure 3.  
Figure 4 presents the AGRs of stem cells publications in different regions. Iran has 
shown a high peak of 600% in 2006, which could be due to the negative rate in 2005. 
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The rates of growth in Iran and in Africa are inconsistent showing some instances of 
random negative and high growth rates.  
Analysis of stem cells publications related to the field of tissue engineering and 
regenerative medicine showed some interesting findings (table 7). In this category, the 
countries could be classified into two groups of high and moderate growth and Iran is 
included in the group with moderate growth. The growth rate of Iran is the same as 
the rate of Middle East and so, Iran is considered as a dominant country in the region 
for this category. The growth models in this area are presented in figure 5. The 
inconsistency in the Iranian annual growth rate is observed in the same way that was 
described for the general stem cells publications.  
Discussion and conclusion  
This study reports that the publication output of Iranian biomedical scientists in the 
field of tissue engineering and regenerative medicine shows a growth rate consistent 
with the general growth rate in the Middle East and other countries with moderate 
growth rate. However, the same pattern is not observed in regards to the stem cell 
research publications. The basic stem cell research is following a low rate of growth 
in Iran. The findings of the current study show that Iran is a dominant country in the 
field of tissue engineering in the region but this is not true about the general stem cell 
research. This dichotomous observation could be a reflection of the interest of Iranian 
biomedical scientists to applied research, which arises from the immediate needs of 
biomedical community.  
As a general rule, the needs determine the field of research and highly affect its 
sustainability. Annual growth rate (AGR) is one of the well established indicators for 
assessment of sustainability. AGR for the Iranian tissue engineering publications 
8 
 
shows an organized steady pattern of growth. However, AGR for Iranian general stem 
cells publications shows an unpredicted and random pattern of growth, which is a 
reflection of instability of research in this field.  
In Iran, stability and regional dominance in the field of regenerative medicine 
research, which receives the same degree of support as stem cells, is an indication of 
natural selection of this field by biomedical scientists and its prioritization over that of 
general stem cells research. This natural selection should be supported and followed 
by policy makers in order to take advantage of current research interests and 
capabilities. The finding that, in the last decade, the growth rate of Iranian tissue 
engineering publications did not show any statistically significant difference with a 
developed country like Australia is an emphasis to the importance of natural selection. 
Therefore, it is recommended to view and manage stem cells research as a part of 
regenerative medicine not vice versa.  
A combined bibliometric and questionnaire-based study is recommended to 
complement this brief assessment and determine the Iranian biomedical community’s 
needs for policy interventions.   
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Table 1. MeSH terms used for retrieval of information from PubMed 
MeSH term Date of introduction 
Regeneration (first introduced as bone regeneration) 1965 
Biocompatible Materials 1972 
Stem cells 1984 
Cell Transplantation 1994 
Bioartificial Organs 2001 
Tissue engineering 2002 
Regenerative Medicine 2004 
Guided Tissue Regeneration 2005 
Tissue Scaffolds 2008 
Cell engineering 2012 
 
 
Table 2. Distribution of tissue engineering and regenerative medicine publications  
Date Europe 
North 
America 
South 
America Australia Africa
East 
Asia 
Central 
Asia 
South 
Asia 
Middle 
East Iran 
2001 2254 2709 101 152 31 1027 1 70 142 4 
2002 2693 3051 125 145 31 1292 0 73 129 4 
2003 2896 3424 151 155 32 1628 0 105 161 7 
2004 3087 3645 148 208 40 2008 1 116 223 15 
2005 3461 3954 154 219 56 2186 1 128 199 19 
2006 3598 4151 223 253 39 2299 137 236 35 
2007 3658 4039 257 289 55 2546 1 167 278 58 
2008 3998 4407 302 269 77 2685 0 169 289 76 
2009 4166 4606 342 301 79 3001 1 244 349 93 
2010 4450 4866 412 337 97 3182 0 235 362 106 
2011 4585 4830 377 365 105 3322 0 321 418 129 
Total 38846 43682 2592 2693 642 25176 5 1765 2786 546 
 
 
Table 3. Distribution of stem cells publications  
Date Europe 
North 
America 
South 
America Australia Africa
East 
Asia 
Central 
Asia 
South 
Asia 
Middle 
East Iran 
2001 808 1232 18 58 5 379 1 5 41 0 
2002 917 1556 21 70 1 465 0 7 45 0 
2003 1061 1597 28 88 0 614 0 19 56 2 
2004 1119 1896 35 94 5 795 0 14 78 4 
2005 1340 2040 40 105 4 1017 0 31 67 2 
2006 1579 2368 50 133 6 1213 0 34 131 14 
2007 1789 2534 48 147 4 1441 0 38 118 28 
2008 2124 3017 67 143 5 1794 1 44 134 24 
2009 2253 3040 77 185 18 1789 0 85 149 35 
2010 2573 3339 114 210 10 2198 1 85 170 46 
2011 2720 3486 118 202 22 2389 1 95 207 75 
Total 18283 26105 616 1435 80 14094 4 457 1196 230 
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Table 4. Distribution of stem cells publications in the field of tissue engineering and regenerative 
medicine  
Date Europe 
North 
America 
South 
America Australia Africa
East 
Asia 
Central 
Asia 
South 
Asia 
Middle 
East Iran 
2001 110 207 2 12 2 56 0 2 10 0 
2002 181 334 3 7 0 98 0 3 11 0 
2003 235 373 5 17 0 136 0 5 14 0 
2004 256 457 4 20 0 201 0 4 27 0 
2005 332 499 7 22 3 274 0 7 22 0 
2006 406 600 6 40 1 318 0 6 39 0 
2007 428 607 8 36 1 387 0 8 32 11 
2008 492 722 9 35 1 455 0 9 35 5 
2009 552 714 24 42 5 469 0 24 48 12 
2010 640 825 24 38 3 602 0 24 46 12 
2011 648 815 22 46 8 617 0 22 57 23 
Total 4280 6153 114 315 24 3613 0 114 341 63 
 
 
 
 
 
 
 
 
 
 
Table 5. The slopes of the linear models of tissue engineering and regenerative medicine 
publication growth in each geographic area  
Group Region Slope ± SE 
Intergroup 
P Value* 
Between groups 
P Value* 
Highest growth rate East Asia 171.4 ± 32.51 P > 0.05 P < 0.05 
Europe 155.6 ± 39.48 
North America 136.3 ± 43.72 
    
Moderate growth rate South America 24.69 ± 4.741 P > 0.05 
Middle East 21.77 ± 3.990 
South Asia 18.99 ± 2.805 
Australia 16.62 ± 3.560 
Iran 11.90 ± 1.211 
    
Low growth rate Africa 5.955 ± 1.266  
* Prism’s ANCOVA-based analysis for comparison of slopes in linear regression model 
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Table 6. The slopes of the linear models of stem cells publication growth in each 
geographic area  
Group Region Slope ± SE 
Intergroup 
P Value* 
Between groups 
P Value* 
Highest growth rate North America 231.5 ± 8.492 P > 0.05 P < 0.05 
East Asia 208.4 ± 8.457 
Europe 202.0 ± 9.591 
    
Moderate growth rate Middle East 16.11 ± 1.357 P > 0.05 
Australia 15.55 ± 0.9687 
    
Low growth rate South Asia 9.336 ± 1.019 P > 0.05 
South America 9.918 ± 1.101 
Iran 6.582 ± 0.9907 
    
Very low growth rate Africa 1.591 ± 0.4401  
* Prism’s ANCOVA-based analysis for comparison of slopes in linear regression model 
 
 
 
 
 
 
 
Table 7. The slopes of the linear models of growth of stem cells publication related to 
tissue engineering and regenerative medicine in each geographic area  
Group Region Slope ± SE 
Intergroup 
P Value* 
Between groups 
P Value* 
High growth rate East Asia 60.70 ± 9.701 P > 0.05 P < 0.05 
Europe 58.80 ± 6.737 
North America 51.90 ± 12.31 
    
Moderate growth rate Middle East 6.100 ± 1.170 P > 0.05 
South America 4.300 ± 1.656 
South Asia 4.290 ± 1.546 
Australia 2.300 ± 1.005 
Iran 3.100 ± 1.561 
Africa 1.600 ± 0.5657 
* Prism’s ANCOVA-based analysis for comparison of slopes in linear regression model 
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Figure 1. The linear models of tissue engineering and regenerative medicine 
publications growth in Iran and other world regions 
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Figure 2. The annual growth rates of tissue engineering and regenerative 
medicine publications in Iran and other world regions  
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Figure 3. The linear models of stem cells publications growth in Iran and other 
world regions 
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Figure 4. The annual growth rates of stem cells publications in Iran and other 
world regions  
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Figure 5. The linear models of growth of stem cells publications related to tissue 
engineering and regenerative medicine in Iran and other world regions 
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Figure 6. The annual growth rates of stem cells publications related to tissue 
engineering and regenerative medicine in Iran and other world regions  
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